← Eichor
Study identifier: NCT04224038 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Inspire Bio-resource Research Platform for Healthy Aging INSPIRE Platform

Condition: Biological Aging  ·  Sponsor: University Hospital, Toulouse

PhaseN/A
Planned participants1000
Who can joinAll sexes, 30 Years to no upper limit
Healthy volunteersYes

About this study

Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.

This description comes directly from the study's public registry record.

Talk to the study team

Bruno VELLAS, MD  ·  5 61 77 70 47  ·  vellas.b@chu-toulouse.fr

Sophie GUYONNET, PhD  ·  5 61 77 70 43  ·  guyonnet.s@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital ToulouseToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04224038